latest update:
[RxAtlas]

drug summary · 2 NDC codes

Rexulti

BREXPIPRAZOLE

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 110638NDC codes 2application NDA205422RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameBREXPIPRAZOLE
active ingredientsnot reported
dosage formKIT
routenot reported
strengthnot reported
marketing statusNDA
DEA schedulenot reported
application numberNDA205422
ATC codenot reported
RxCUInot reported
manufacturerOtsuka America Pharmaceutical, Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classAtypical Antipsychotic [EPC]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
59148-042—
59148004207—

Other BREXPIPRAZOLE products

6 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.